1-7 of 7
John Nicoll
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CBL , CBLB , TET2 , ASXL1 , and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

e-blood
Hideki Makishima, Anna M. Jankowska, Michael A. McDevitt, Christine O'Keefe, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Harish Siddaiah, Mohammed Shaik, Hadrian Szpurka, Eric Hsi, Anjali Advani, Ronald Paquette, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2011) 117 (21): e198–e206.
https://doi.org/10.1182/blood-2010-06-292433
Published: 2011
Includes: Supplemental data
Journal Articles

CBL, CBLB, TET2, ASXL1 , and IDH1/2 Mutations as Well as Additional Chromosomal Aberrations Constitute Molecular Events Contributing to Malignant Progression In Advanced Philadelphia Chromosome-Positive Disorders.

Hideki Makishima, MD, PhD, Anna Jankowska, MSC, Michael A McDevitt, MD, PhD, Simon Dujardin, Heather Cazzolli, Bartlomiej Przychodzen, Courtney Prince, John Nicoll, Siddaiah Harish, MD, Mohammed Shaik, MD, Eric Hsi, MD, Anjali Advani, MD, Ronald Paquette, MD, Jaroslaw P Maciejewski, MD, PhD, FACP
Journal: Blood
Blood (2010) 116 (21): 3396.
https://doi.org/10.1182/blood.V116.21.3396.3396
Published: 2010
Journal Articles

Clonal Hematopoiesis in Philadelphia Chromosome-Negative Bone Marrow Cells of Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors

Ron Paquette, MD, John Nicoll, Meenal Chalukya, Lukasz P Gondek, MD, PhD, Monika Jasek, Charles Sawyers, MD, Neil Shah, MD, PhD, Jaroslaw Maciejewski
Journal: Blood
Blood (2008) 112 (11): 575.
https://doi.org/10.1182/blood.V112.11.575.575
Published: 2008
Journal Articles

MicroRNA-155 Promotes Myeloid Proliferation and Is Overexpressed in Acute Myeloid Leukemia.

Dinesh S. Rao, MD, Ryan M. O’Connell, Ph.D., Aadel A. Chaudhuri, Mark Boldin, Ph.D., Konstantin Taganov, Ph.D., John Nicoll, Ronald Paquette, M.D., David Baltimore, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 715.
https://doi.org/10.1182/blood.V110.11.715.715
Published: 2007
Journal Articles

Major Molecular Responses to Dasatinib (BMS-354825) Are Observed in Imatinib-Resistant Late Stage Chronic and Advanced CML Patients: Impact and Fate of Imatinib-Resistant Clones in Dasatinib-Treated Patients.

Susan Branford, Timothy Hughes, John Nicoll, Ron Paquette, Eric Bleickardt, Charles Sawyers, Neil Shah
Journal: Blood
Blood (2005) 106 (11): 437.
https://doi.org/10.1182/blood.V106.11.437.437
Published: 2005
Journal Articles

Hematologic and Cytogenetic Responses in Imatinib-Resistant Chronic Phase Chronic Myeloid Leukemia Patients Treated with the Dual SRC/ABL Kinase Inhibitor BMS-354825: Results from a Phase I Dose Escalation Study.

Charles L. Sawyers, Neil P. Shah, Hagop M. Kantarjian, Nicholas Donato, John Nicoll, Stephen A. Bai, Fei Huang, Edwin Clark, Arthur P. DeCillis, Moshe Talpaz
Journal: Blood
Blood (2004) 104 (11): 1.
https://doi.org/10.1182/blood.V104.11.1.1
Published: 2004
Journal Articles

Hematologic and Cytogenetic Responses in Imatinib-Resistant Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) Patients Treated with the Dual SRC/ABL Kinase Inhibitor BMS-354825: Results from a Phase I Dose Escalation Study.

Moshe Talpaz, Hagop Kantarjian, Neil P. Shah, Nicholas Donato, John Nicoll, Stephen A. Bai, Fei Huang, Edwin Clark, Arthur P. DeCillis, Charles Sawyers
Journal: Blood
Blood (2004) 104 (11): 20.
https://doi.org/10.1182/blood.V104.11.20.20
Published: 2004